Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bromocriptine"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 3852
Tytuł:
Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's disease.
Autorzy:
Debnath S; Department of Genetics and Plant Breeding, Institute of Agriculture, Visva-Bharati University, Sriniketan, West Bengal, India.
Sharma D; Department of Biochemistry, ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra, Uttar Pradesh, India.
Chaudhari SY; Department of Pharmaceutical Chemistry, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune, India.
Sharma R; Department University Institute of Pharma Sciences, Chandigarh University, Chandigarh, India.
Shaikh AA; Department of Pharmaceutics, SCES's Indira College of Pharmacy 'Niramay', Tathwade, Pune, Maharashtra, India.
Buchade RS; Department of Pharmaceutics, SCES's Indira College of Pharmacy 'Niramay', Tathwade, Pune, Maharashtra, India.
Kesari KK; Department of Applied Physics, School of Science, Aalto University, Espoo, Finland.
Abdel-Fattah AM; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
Algahtani M; Department of Laboratory & Blood Bank, Security Forces Hospital, Meca, Saudi Arabia.
Mheidat M; Medicine Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Alsaidalani R; Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Paul T; Department of Genetics and Plant Breeding, Institute of Agriculture, Visva-Bharati University, Sriniketan, West Bengal, India.
Sayed AA; Zoology Department, Faculty of Science, Cairo University, Giza, Egypt.
Abdel-Daim MM; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.; Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jan 19; Vol. 18 (1), pp. e0279616. Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/drug therapy
Alzheimer Disease*/metabolism
Bromocriptine*/pharmacology
Claviceps*
Intracranial Aneurysm*/prevention & control
Toll-Like Receptor 4*/metabolism
Humans ; Molecular Docking Simulation ; Triticum/microbiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Comparative Pharmaco- and Histokinetics of the Therapeutic Dose of Estradiol Valerate and Bromocriptine in Common Quails.
Autorzy:
Nadeem M; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Nisa MU; Basic Health Unit, Khuda Bakhsh Mahar District Bahawalpur, Pakistan.
Bangash MH; Basic Health Unit 14/8R, Khanewal, Pakistan.
Abideen ZU; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Sattar R; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Sattar H; Department of Biotechnology, The University of Lahore, Pakistan.
Ullah MS; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Ruby T; Department of Zoology, Bahauddin Zakariya University, Multan, Pakistan.
Khan AA; Department of Zoology, Bahauddin Zakariya University, Multan, Pakistan.
Ahmad A; University of Chinese Academy of Science (UCAS), Beijing, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2022 Oct 11; Vol. 2022, pp. 5482895. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).
Typ publikacji:
Journal Article; Retracted Publication
MeSH Terms:
Coturnix*/physiology
Bromocriptine*/pharmacology
Animals ; Female ; Male ; Estradiol ; Mesylates
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
Autorzy:
Cincotta AH; VeroScience LLC, Tiverton, RI 02878, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 26; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Metabolic Syndrome*/drug therapy
Insulin Resistance*
Cardiovascular Diseases*
Animals ; Bromocriptine ; Dopamine ; Brain ; Insulin, Regular, Human ; Dopamine Agonists ; Insulin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature.
Autorzy:
Li D; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.; Department of Health Management, Health Management Center, General Practice Center, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Wang Y; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Tan H; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China. .
Luo P; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Yu Y; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2023 May 12; Vol. 23 (1), pp. 107. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Prolactinoma*/diagnosis
Prolactinoma*/diagnostic imaging
Pituitary Neoplasms*/diagnosis
Pituitary Neoplasms*/diagnostic imaging
Male ; Humans ; Young Adult ; Adult ; Epistaxis/complications ; Epistaxis/drug therapy ; Prolactin ; Bromocriptine/therapeutic use ; Magnetic Resonance Imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review.
Autorzy:
Birhan, Mulualem Tesfaye (AUTHOR)
Ayele, Teklie Mengie (AUTHOR)
Abebe, Fikire Wondimu (AUTHOR)
Dgnew, Fiseha Nigussie (AUTHOR)
Pokaż więcej
Źródło:
Diabetology & Metabolic Syndrome. 7/17/2023, Vol. 15 Issue 1, p1-7. 7p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma.
Autorzy:
Igata M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yagi Y; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Hanatani S; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Sakaguchi M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ishii N; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yoshinaga K; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kawashima J; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Motoshima H; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2021 Apr; Vol. 12 (4), pp. 668-671. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji:
Case Reports
MeSH Terms:
Blood Glucose/*drug effects
Bromocriptine/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Dopamine Agonists/*therapeutic use
Prolactinoma/*drug therapy
Bromocriptine/pharmacology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Dopamine Agonists/pharmacology ; Female ; Humans ; Middle Aged ; Prolactinoma/complications
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism.
Autorzy:
Hsu, Chih-Neng (AUTHOR)
Hsuan, Chin-Feng (AUTHOR)
Liao, Daniel (AUTHOR)
Chang, Jack Keng-Jui (AUTHOR)
Chang, Allen Jiun-Wei (AUTHOR)
Hee, Siow-Wey (AUTHOR)
Lee, Hsiao-Lin (AUTHOR)
Teng, Sean I. F. (AUTHOR)
Pokaż więcej
Źródło:
Life (2075-1729). Apr2023, Vol. 13 Issue 4, p1024. 32p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation.
Autorzy:
Aguayo-Cerón KA; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.
Calzada-Mendoza CC; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.
Méndez-Bolaina E; Facultad de Ciencias Químicas, Universidad Veracruzana , Veracruz, México.
Romero-Nava R; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.; Departamento de Farmacología, Hospital Infantil de México Federico Gómez (HIMFG) , México City, México.
Ocharan-Hernández ME; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2020 Oct 02; Vol. 42 (7), pp. 675-679. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Bromocriptine/*pharmacology
Cardiomegaly/*metabolism
Dopamine Agonists/*pharmacology
Myocardium/*metabolism
Receptors, Dopamine D2/*metabolism
Receptors, Prolactin/*metabolism
Animals ; Bromocriptine/metabolism ; Bromocriptine/therapeutic use ; Cardiomegaly/prevention & control ; Male ; Rats ; Receptors, Dopamine D2/agonists
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.
Autorzy:
Elyasi F; Sexual and Reproductive Health Research Center, Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.; Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Sadati S; Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Heydari F; Department of Anesthesiology and Critical Care Medicine, Imam Khomeini Hospital, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2023 Mar; Vol. 43 (1), pp. 154-159. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Case Reports
MeSH Terms:
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/drug therapy
Neuroleptic Malignant Syndrome*/etiology
Antipsychotic Agents*/adverse effects
Psychotic Disorders*/drug therapy
Male ; Humans ; Middle Aged ; Flupenthixol/therapeutic use ; Bromocriptine/therapeutic use
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Insulin and Leptin Levels in Blood and Brain Structures of Rats with Diet-Induced Obesity and the Effect of Various Drugs on Them.
Autorzy:
Derkach, K. V. (AUTHOR)
Sorokoumov, V. N. (AUTHOR)
Bakhtyukov, A. A. (AUTHOR)
Bondareva, V. M. (AUTHOR)
Shpakov, A. O. (AUTHOR)
Pokaż więcej
Źródło:
Journal of Evolutionary Biochemistry & Physiology. Nov2022, Vol. 58 Issue 6, p1892-1904. 13p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
Autorzy:
Cincotta AH; VeroScience LLC, Tiverton, RI 02878, USA.
Cersosimo E; Texas Diabetes Institute, University Health System, San Antonio, TX 78207, USA.; Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Alatrach M; Texas Diabetes Institute, University Health System, San Antonio, TX 78207, USA.; Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Ezrokhi M; VeroScience LLC, Tiverton, RI 02878, USA.
Agyin C; Texas Diabetes Institute, University Health System, San Antonio, TX 78207, USA.; Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Adams J; Texas Diabetes Institute, University Health System, San Antonio, TX 78207, USA.; Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Chilton R; Texas Diabetes Institute, University Health System, San Antonio, TX 78207, USA.; Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Triplitt C; Texas Diabetes Institute, University Health System, San Antonio, TX 78207, USA.; Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Chamarthi B; VeroScience LLC, Tiverton, RI 02878, USA.
Cominos N; VeroScience LLC, Tiverton, RI 02878, USA.
DeFronzo RA; Texas Diabetes Institute, University Health System, San Antonio, TX 78207, USA.; Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Aug 09; Vol. 23 (16). Date of Electronic Publication: 2022 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiovascular Diseases*/epidemiology
Diabetes Mellitus, Type 2*
Bromocriptine/pharmacology ; Bromocriptine/therapeutic use ; Glycogen Synthase Kinase 3 beta ; Humans ; Interleukin-18 ; L-Selectin ; Leukocytes, Mononuclear ; NF-E2-Related Factor 2 ; NIMA-Interacting Peptidylprolyl Isomerase ; NLR Family, Pyrin Domain-Containing 3 Protein ; Normetanephrine ; Oxidative Stress ; Phenotype ; Prolactin ; RNA, Messenger ; Superoxide Dismutase-1 ; Sympatholytics ; Thiobarbituric Acid Reactive Substances ; Toll-Like Receptor 2 ; Toll-Like Receptor 4
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of Dopaminergic Drugs on Cognitive Control Processes Vary by Genotype.
Autorzy:
Furman DJ; University of California, Berkeley.
White RL 3rd; University of California, Berkeley.; Washington University School of Medicine.
Naskolnakorn J; University of California, Berkeley.
Ye J; University of California, Berkeley.
Kayser A; University of California, San Francisco.
D'Esposito M; University of California, Berkeley.
Pokaż więcej
Źródło:
Journal of cognitive neuroscience [J Cogn Neurosci] 2020 May; Vol. 32 (5), pp. 804-821. Date of Electronic Publication: 2020 Jan 06.
Typ publikacji:
Journal Article
MeSH Terms:
Bromocriptine/*pharmacology
Catechol O-Methyltransferase/*genetics
Catechol O-Methyltransferase Inhibitors/*pharmacology
Cerebral Cortex/*metabolism
Corpus Striatum/*metabolism
Dopamine/*metabolism
Dopamine Agonists/*pharmacology
Executive Function/*drug effects
Psychomotor Performance/*drug effects
Tolcapone/*pharmacology
Adult ; Bromocriptine/administration & dosage ; Catechol O-Methyltransferase Inhibitors/administration & dosage ; Dopamine Agonists/administration & dosage ; Female ; Humans ; Male ; Tolcapone/administration & dosage ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Long-term low-dose cabergoline usage: Another association with cardiac valvulopathy.
Autorzy:
Tessier S; Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Lipton BA; Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Arastu MI; Department of Internal Medicine, St. Luke's Health Network, Bethlehem, Pennsylvania, USA.
Curiale AM; Department of Cardiology, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Longo S; Department of Pathology, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Nanda S; Department of Cardiology, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Pokaż więcej
Źródło:
Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2023 Jan; Vol. 40 (1), pp. 61-64. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Heart Valve Diseases*/diagnostic imaging
Heart Valve Diseases*/drug therapy
Heart Valve Diseases*/complications
Pituitary Neoplasms*/complications
Pituitary Neoplasms*/drug therapy
Humans ; Middle Aged ; Cabergoline ; Bromocriptine ; Ergolines/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report
Autorzy:
Angulo NY; Toxicología Clínica y Farmacovigilancia, IPS Universitaria Clínica León XIII, Medellín, Colombia. .
Castaño PA; Toxicología Clínica y Farmacovigilancia, IPS Universitaria Clínica León XIII, Medellín, Colombia. .
Gómez CC; Sección de Medicina de Urgencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. .
Quintero S; Sección de Medicina de Urgencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. .
Pokaż więcej
Transliterated Title:
Síndrome neuroléptico maligno asociado con intoxicación aguda por un organofosforado: reporte de caso.
Źródło:
Biomedica : revista del Instituto Nacional de Salud [Biomedica] 2022 Sep 02; Vol. 42 (3), pp. 445-449. Date of Electronic Publication: 2022 Sep 02.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Antipsychotic Agents*/adverse effects
Chlorpyrifos*/therapeutic use
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/etiology
Neuroleptic Malignant Syndrome*/therapy
Organophosphate Poisoning*/complications
Bromocriptine/therapeutic use ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Bromocriptine therapy: Review of mechanism of action, safety and tolerability.
Autorzy:
Naz F; Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan.
Malik A; College of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Riaz M; Department of Allied Health Sciences, University of Sargodha, Sargodha, Pakistan.
Mahmood Q; College of Pharmacy, University of Sargodha, Sargodha, Pakistan.; Department of Pharmaceutical Sciences, Biomanufacturing Research Institute & Technology Enterprise, North Carolina Central University, Durham, NC, USA.
Mehmood MH; Department of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.
Rasool G; Department of Allied Health Sciences, University of Sargodha, Sargodha, Pakistan.
Mahmood Z; Department of Biochemistry, Government College University, Faisalabad, Pakistan.
Abbas M; Department of Biochemistry, University of Veterinary and Animal Sciences Lahore (Jhang Campus), Lahore, Pakistan.
Pokaż więcej
Źródło:
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2022 Aug; Vol. 49 (8), pp. 903-922. Date of Electronic Publication: 2022 Jun 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Acromegaly*/complications
Acromegaly*/drug therapy
Diabetes Mellitus, Type 2*/complications
Hyperprolactinemia*/complications
Hyperprolactinemia*/drug therapy
Pituitary Neoplasms*/complications
Pituitary Neoplasms*/drug therapy
Bromocriptine/adverse effects ; Dopamine Agonists/adverse effects ; Humans ; Prolactin/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta-analysis.
Autorzy:
Hoevelmann J; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University Hospital, Homburg, Germany.
Engel ME; Division of Cardiology, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Muller E; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Hohlfeld A; South African Medical Research Council, Cape Town, South Africa.
Böhm M; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University Hospital, Homburg, Germany.
Sliwa K; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Division of Cardiology, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Medicine, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Viljoen C; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Division of Cardiology, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Medicine, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Sep; Vol. 24 (9), pp. 1719-1736. Date of Electronic Publication: 2022 Jul 26.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathies*/drug therapy
Cardiomyopathies*/epidemiology
Heart Failure*/complications
Heart Failure*/epidemiology
Heart Failure*/therapy
Pregnancy Complications, Cardiovascular*/epidemiology
Pregnancy Complications, Cardiovascular*/therapy
Puerperal Disorders*/epidemiology
Puerperal Disorders*/therapy
Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Bromocriptine ; Cabergoline ; Cardiotonic Agents ; Cross-Sectional Studies ; Female ; Humans ; Peripartum Period ; Pregnancy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.
Autorzy:
Palle S; a DMPK & Clinical Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University , Warangal , India.
Neerati P; a DMPK & Clinical Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University , Warangal , India.
Pokaż więcej
Źródło:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2018 Oct; Vol. 48 (10), pp. 1028-1036. Date of Electronic Publication: 2017 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Bromocriptine/*pharmacokinetics
Cytochrome P-450 CYP3A/*metabolism
Cytochrome P-450 CYP3A Inhibitors/*pharmacokinetics
Cytochrome P-450 CYP3A Inhibitors/*pharmacology
Intestines/*enzymology
Liver/*enzymology
Nanoparticles/*chemistry
Quercetin/*pharmacology
Administration, Oral ; Animals ; Biological Transport/drug effects ; Bromocriptine/administration & dosage ; Bromocriptine/blood ; Bromocriptine/pharmacology ; Calibration ; Cytochrome P-450 CYP3A Inhibitors/administration & dosage ; Cytochrome P-450 CYP3A Inhibitors/blood ; Male ; Microsomes/drug effects ; Microsomes/enzymology ; Nanoparticles/ultrastructure ; Permeability ; Rats, Wistar
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 3852

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies